K. Somers

发表

Suppression of ABCE1-Mediated mRNA Translation Limits N-MYC–Driven Cancer Progression

R. Pearson, J. Fletcher, R. Hannan, 2020, Cancer Research.

Effective targeting of NAMPT in patient-derived xenograft models of high-risk pediatric acute lymphoblastic leukemia

B. Teicher, U. Kees, A. Gudkov, 2019, Leukemia.

The Use of Phages and Aptamers as Alternatives to Antibodies in Medical and Food Diagnostics

M. Scippo, J. Robbens, R. Blust, 2011 .

Direct targeted therapy for MLL‐fusion‐driven high‐risk acute leukaemias

J. Martens, J. Klusmann, A. Warren, 2022, Clinical and translational medicine.

Reveals Novel Antigenic Candidates Autoantibody Profiling in Multiple Sclerosis

P. Stinissen, R. Medaer, V. Somers, 2008 .

Autoantibody Profiling in Multiple Sclerosis

P. Stinissen, R. Medaer, V. Somers, 2008 .

Optimization of High‐throughput Autoantibody Profiling for the Discovery of Novel Antigenic Targets in Rheumatoid Arthritis

P. Stinissen, V. Somers, K. Somers, 2009, Annals of the New York Academy of Sciences.

Autoantibodies to two novel peptides in seronegative and early rheumatoid arthritis.

P. Geusens, P. Stinissen, A. H. M. van der Helm-van Mil, 2016, Rheumatology.

Novel autoantibody markers for early and seronegative rheumatoid arthritis.

P. Geusens, M. Coenen, D. Elewaut, 2011, Journal of autoimmunity.

Potent antileukemic activity of curaxin CBL0137 against MLL‐rearranged leukemia

U. Kees, A. Gudkov, R. Lock, 2020, International journal of cancer.

Analysis of antibody reactivity in paired cerebrospinal fluid and serum of a relapsing remitting multiple sclerosis patient

P. Stinissen, R. Hupperts, V. Somers, 2009, Autoimmunity.

The Combination of Curaxin CBL0137 and Histone Deacetylase Inhibitor Panobinostat Delays KMT2A-Rearranged Leukemia Progression

A. Gudkov, R. Johnstone, R. Lock, 2022, Frontiers in Oncology.

Systematic In Vitro Evaluation of a Library of Approved and Pharmacologically Active Compounds for the Identification of Novel Candidate Drugs for KMT2A-Rearranged Leukemia

M. Kavallaris, M. Haber, M. Henderson, 2022, Frontiers in Oncology.

Frameshifting in the P6 cDNA Phage Display System

P. Stinissen, V. Somers, K. Somers, 2010, Molecules.

Citrulline‐modified phage display: A novel high‐throughput discovery approach for the identification of citrulline‐containing ligands

P. Stinissen, V. Somers, K. Somers, 2011, Proteomics.

Cell-penetrating Alphabody protein scaffolds for intracellular drug targeting

I. Lasters, J. Desmet, S. Savvides, 2021, Science Advances.

OT-82, a novel anticancer drug candidate that targets the strong dependence of hematological malignancies on NAD biosynthesis

M. Antoch, P. Komarov, A. Gudkov, 2020, Leukemia.

Identification of a genetic variant for joint damage progression in autoantibody-positive rheumatoid arthritis

P. Gregersen, J. Houwing-Duistermaat, T. Huizinga, 2013, Annals of the rheumatic diseases.

Exploring cDNA Phage Display for Autoantibody Profiling in the Serum of Multiple Sclerosis Patients

P. Stinissen, R. Hupperts, V. Somers, 2007, Annals of the New York Academy of Sciences.

Dual Targeting of Chromatin Stability By The Curaxin CBL0137 and Histone Deacetylase Inhibitor Panobinostat Shows Significant Preclinical Efficacy in Neuroblastoma

J. Pettitt, N. Issaeva, A. Gudkov, 2021, Clinical Cancer Research.

Immunometabolism: A 'Hot' Switch for 'Cold' Pediatric Solid Tumors.

M. Haber, M. Norris, K. Somers, 2021, Trends in cancer.

Autoantibody Profiling in Multiple Sclerosis Reveals Novel Antigenic Candidates1

P. Stinissen, R. Hupperts, R. Medaer, 2008, The Journal of Immunology.

A novel small molecule that kills a subset of MLL-rearranged leukemia cells by inducing mitochondrial dysfunction

A. Osterman, C. Supuran, R. Pearson, 2019, Oncogene.

Structural basis of IL-23 antagonism by an Alphabody protein scaffold

I. Lasters, J. Desmet, S. Savvides, 2014, Nature Communications.

Sperm-Associated Antigen 16 Is a Novel Target of the Humoral Autoimmune Response in Multiple Sclerosis

M. Verbeek, P. Jongen, M. D'hooghe, 2014, The Journal of Immunology.

Response in Multiple Sclerosis Target of the Humoral Autoimmune Sperm-Associated Antigen 16 Is a Novel

Niels, M. Verbeek, P. Jongen, 2014 .

Novel cerebrospinal fluid and serum autoantibody targets for clinically isolated syndrome

M. Verbeek, C. Sindic, J. Álvarez-cermeño, 2012, Journal of neurochemistry.

Multiplexing approaches for autoantibody profiling in multiple sclerosis.

Veerle Somers, P. Stinissen, Piet Stinissen, 2009, Autoimmunity reviews.

Exploiting the reactive oxygen species imbalance in high-risk paediatric acute lymphoblastic leukaemia through auranofin

U. Kees, R. Lock, M. Haber, 2021, British Journal of Cancer.

ABCC4/MRP4 contributes to the aggressiveness of Myc‐associated epithelial ovarian cancer

J. George, D. Bowtell, C. Scott, 2020, International journal of cancer.

Construction of helper plasmid-mediated dual-display phage for autoantibody screening in serum

K. Rajaram, L. Michiels, V. Vermeeren, 2014, Applied Microbiology and Biotechnology.

Delivery of PEGylated liposomal doxorubicin by bispecific antibodies improves treatment in models of high-risk childhood leukemia

Christopher B. Howard, Yizhou Huang, J. Pimanda, 2023, Science Translational Medicine.

Identification of a genetic variant for joint damage progression in autoantibody-positive rheumatoid arthritis

P. Gregersen, J. Houwing-Duistermaat, T. Huizinga, 2013, Annals of the rheumatic diseases.

FDA-approved disulfiram as a novel treatment for aggressive leukemia

M. Haber, M. Henderson, M. Norris, 2024, Journal of molecular medicine.

CCI-007, a novel small molecule with cytotoxic activity against infant leukemia with MLL rearrangements

Andrei V. Gudkov, U. Kees, A. Gudkov, 2016, Oncotarget.

Multiplexing approaches for autoantibody profiling in multiple sclerosis.

P. Stinissen, V. Somers, K. Somers, 2009, Autoimmunity reviews.